We are monitoring the impact of COVID-19 on MEA Clinical Trials Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1575
Share on
Share on

Middle East & Africa Clinical Trials Market Analysis – Segmented By Phase, Design, Indications, By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecast | 2020 – 2025

Pulished: February, 2020
ID: 1575
Pages: 145

As per our report, the size of the Middle East and Africa Clinical Trials Market was valued at USD 1.36 Billion in 2020 and is projected to reach USD 1.95 Billion by 2025 at a CAGR of 7.55% during the forecast period from 2020 to 2025.

The Middle East clinical trial market can be seen as a new opportunity for investment. The emergence of advanced technology is levelling up the growth rate of the market. There is a highly qualified and skilled workforce available in these countries, which are propelling market growth. The government is also providing fund for the clinical trials. An increasing number of clinical trials due to rising cases of COVID-19 is one of the factors driving the market. There are many local CROs in this region which carry out clinical trials. The University of Baghdad has launched clinical trials for COVID – 19 using Ivermectin in the Middle East. This is the key factor which is propelling the market growth in the Middle East.  

The ratio of a clinical trial carried out in the African region is uneven. The funding provided in these countries is also uneven like South Africa invests more in a clinical trial compared to other African countries. There is no proper healthcare infrastructure present in most of the African countries. These are some challenges faced by the clinical trial market in Africa. The healthcare regulatory bodies in Africa are collaborating to conduct clinical trials for COVID -19.   

MARKET DRIVERS

The market for Clinical Trials is mainly driven due to alliances between the pharma-biotech companies and the clinical research organizations, increasing demand for outsourcing clinical development and increasing demand for innovative solutions in the healthcare industry. Excessive R&D investment in the healthcare industry, the risen prevalence of chronic diseases, increased outsourcing of clinical research and implementation of clinical trials by contract research organizations, and assimilation of clinical trial management systems with hospital information systems are key parameters promoting the market growth. A consequent rise in clinical trials in these countries should be associated with high population growth, demand for drugs, increased incidence of lifestyle linked and unusual genetic diseases in the MEA countries.

MARKET CHALLENGES

But, the market growth can be hampered due to the emerging shortage of clinical resources such as lack of disease population, well-trained labour, and sound medical infrastructure are delaying the process to initiate trials.

This report on MEA Clinical Trails Market has been segmented into the following categories:

  • By Phase – Phase I, Phase II, Phase III
  • By Design - Interventional trials, Observational trials, Expanded Access trials
  • By Indications – Autoimmune, Blood disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental disorders, Metabolic, Musculoskeletal, Nose & Ophthalmology  
  • By Country – KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Geographically, the Clinical Trials market in the Middle East and Africa region is projected to grow at the high CAGR. Emerging countries account for the largest share due to support from the respective government bodies and growing trend of rising strategic alliances, joint ventures and acquisitions of qualified investigators, all without the competition or cost they face in more developed nations.

Promising companies operating in the MEA Clinical Trails Market profiled in this report are Chiltern, Omnicare, PPD, Parexel, Kendle, Quintles, ICON Plc, and Charles River.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Phases                          

                                5.1.1 Introduction           

                                5.1.2 Phase I      

                                5.1.3 Phase II    

                                5.1.4 Phase III   

                                5.1.5  Y-o-Y Growth Analysis, By Phases                

                                5.1.6  Market Attractiveness Analysis, By Phases              

                                5.1.7  Market Share Analysis, By Phases                

                5.2 Design                          

                                5.2.1 Introduction           

                                5.2.2 Interventional trials             

                                5.2.3 Observational trials             

                                5.2.4 Expanded Access trials       

                                5.2.5  Y-o-Y Growth Analysis, By Design 

                                5.2.6  Market Attractiveness Analysis, By Design               

                                5.2.7  Market Share Analysis, By Design

                5.3 Indications                  

                                5.3.1 Introduction           

                                5.3.2 Autoimmune         

                                5.3.3 Blood disorders     

                                5.3.4 Cancer      

                                5.3.5 Circulatory               

                                5.3.6 CNS            

                                5.3.7 Congenital               

                                5.3.8 CVS            

                                5.3.9 Dermatology          

                                5.3.10 Ear            

                                5.3.11 Gastrointestinal  

                                5.3.12 Genitourinary      

                                5.3.13 Infections              

                                5.3.14 Mental disorders

                                5.3.15 Metabolic              

                                5.3.16 Musculoskeletal 

                                5.3.17 Nose       

                                5.3.18 Ophthalmology   

                                5.3.19  Y-o-Y Growth Analysis, By Indications      

                                5.3.20  Market Attractiveness Analysis, By Indications    

                                5.3.21  Market Share Analysis, By Indications      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Phase

                                                6.1.3.3 By Design

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Phase

                                                6.1.4.3 By Design

                                                6.1.4.4 By Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Phase

                                                6.1.5.3 By Design

                                                6.1.5.4 By Indication

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Chiltern                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Omnicare                    

                8.3 PPD                

                8.4 Parexel                         

                8.5 Kendle                          

                8.6 Quintles                       

                8.7 ICON Plc                       

                8.8 Charles River                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  2. Middle East & Africa Phase I Market By Region, From 2020 - 2025 ( USD Billion )
  3. Middle East & Africa Phase II Market By Region, From 2020 - 2025 ( USD Billion )
  4. Middle East & Africa Phase III Market By Region, From 2020 - 2025 ( USD Billion )
  5. Middle East & Africa Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  6. Middle East & Africa Interventional trials Market By Region, From 2020 - 2025 ( USD Billion )
  7. Middle East & Africa Observational trials Market By Region, From 2020 - 2025 ( USD Billion )
  8. Middle East & Africa Expanded Access trials Market By Region, From 2020 - 2025 ( USD Billion )
  9. Middle East & Africa Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )
  10. Middle East & Africa Autoimmune Market By Region, From 2020 - 2025 ( USD Billion )
  11. Middle East & Africa Blood disorders Market By Region, From 2020 - 2025 ( USD Billion )
  12. Middle East & Africa Cancer Market By Region, From 2020 - 2025 ( USD Billion )
  13. Middle East & Africa Circulatory Market By Region, From 2020 - 2025 ( USD Billion )
  14. Middle East & Africa CNS Market By Region, From 2020 - 2025 ( USD Billion )
  15. Middle East & Africa Congenital Market By Region, From 2020 - 2025 ( USD Billion )
  16. Middle East & Africa CVS Market By Region, From 2020 - 2025 ( USD Billion )
  17. Middle East & Africa Dermatology Market By Region, From 2020 - 2025 ( USD Billion )
  18. Middle East & Africa Ear Market By Region, From 2020 - 2025 ( USD Billion )
  19. Middle East & Africa Gastrointestinal Market By Region, From 2020 - 2025 ( USD Billion )
  20. Middle East & Africa Genitourinary Market By Region, From 2020 - 2025 ( USD Billion )
  21. Middle East & Africa Infections Market By Region, From 2020 - 2025 ( USD Billion )
  22. Middle East & Africa Mental disorders Market By Region, From 2020 - 2025 ( USD Billion )
  23. Middle East & Africa Metabolic Market By Region, From 2020 - 2025 ( USD Billion )
  24. Middle East & Africa Musculoskeletal Market By Region, From 2020 - 2025 ( USD Billion )
  25. Middle East & Africa Nose Market By Region, From 2020 - 2025 ( USD Billion )
  26. Middle East & Africa Ophthalmology Market By Region, From 2020 - 2025 ( USD Billion )
  27. Middle East Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  28. Middle East Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  29. Middle East Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )
  30. Africa Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  31. Africa Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  32. Africa Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample